Editorial expression of concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer,Molecular Cancer

当前位置： X-MOL 学术 › Mol. Cancer › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Editorial expression of concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer
Molecular Cancer ( IF 27.7 ) Pub Date : 2024-10-01 , DOI: 10.1186/s12943-024-02139-z
Claire Corcoran, Sweta Rani, Susan Breslin, Martina Gogarty, Irene M Ghobrial, John Crown, Lorraine O’Driscoll

Correction:Mol Cancer 13, 71 (2014)

https://doi.org/10.1186/1476-4598-13-71

Published: 24 March 2014

After the publication of this article, the publisher was alerted to an apparent panel duplication and frameshift in Fig. 4B migration (ii) SKBR3-LR NC mimic and 4 C invasion (ii) SKBR3-LR NC mimic. Because the issue was detected ten years after publication, the original images for the study are no longer available. The panel has not been replaced. Readers are urged to take caution when interpreting the content and conclusions of this article.

Authors and Affiliations

School of Pharmacy and Pharmaceutical Sciences & Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland
Claire Corcoran, Sweta Rani, Susan Breslin, Martina Gogarty & Lorraine O’Driscoll
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Irene M Ghobrial
Department of Oncology, St. Vincent’s University Hospital, Dublin 4, Ireland
John Crown

Authors

Claire CorcoranView author publications
You can also search for this author in PubMed Google Scholar
Sweta RaniView author publications
You can also search for this author in PubMed Google Scholar
Susan BreslinView author publications
You can also search for this author in PubMed Google Scholar
Martina GogartyView author publications
You can also search for this author in PubMed Google Scholar
Irene M GhobrialView author publications
You can also search for this author in PubMed Google Scholar
John CrownView author publications
You can also search for this author in PubMed Google Scholar
Lorraine O’DriscollView author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lorraine O’Driscoll.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/1476-4598-13-71.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

Cite this article

Corcoran, C., Rani, S., Breslin, S. et al. Editorial expression of concern: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer. Mol Cancer 23, 219 (2024). https://doi.org/10.1186/s12943-024-02139-z

Download citation

Published: 01 October 2024
DOI: https://doi.org/10.1186/s12943-024-02139-z

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

中文翻译：

编辑关注的表达：miR-630 靶向 IGF1R 调节 HER2 过表达乳腺癌对 HER 靶向药物的反应和总体癌细胞进展

Correction:Mol Cancer 13, 71 (2014)

https://doi.org/10.1186/1476-4598-13-71

发布日期：2014 年 3 月 24 日

本文发表后，出版商被警告图 4B 迁移 (ii) SKBR3-LR NC 模拟物和 4 C 入侵 (ii) SKBR3-LR NC 模拟物中存在明显的面板重复和移码。由于该问题在发布十年后才被发现，因此该研究的原始图像已不再可用。面板尚未更换。敬请读者在解读本文内容和结论时务必谨慎。

作者和单位

药学与制药科学学院 & 三一生物医学科学研究所，都柏林三一学院，Dublin 2，爱尔兰

克莱尔·柯克伦、斯韦塔·拉尼、苏珊·布莱斯琳、玛蒂娜·戈加蒂和洛林·奥德里斯科尔
哈佛医学院达纳法伯癌症研究所肿瘤内科，美国马萨诸塞州波士顿
艾琳·M·戈布里尔
圣文森特大学医院肿瘤科，都柏林 4，爱尔兰
约翰·克朗

作者